Varex Imaging Corporation

Varex Imaging Corporation

VREX·NASDAQ

$10.15

+2.1%
HealthcareMedical - Devices

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

At a Glance

Live Snapshot
Market Cap$427.31M
EPS-1.7000
P/E Ratio-5.97
Earnings Date08/06/2026
-3.00%
Return on Invested Capital
-89%
3Y-143.0%
5Y-150.0%
10Y-546.0%
-14.88%
Return on Equity
67%
3Y-275.0%
5Y-362.0%
10Y-528.0%
-6.35%
Return on Assets
62%
3Y-265.0%
5Y-348.0%
10Y-526.0%
Varex Imaging Corporation

Varex Imaging Corporation Management Team

VREX · NASDAQ
MS

Mr. Shubham Maheshwari

Chief Financial Officer & Principal Accounting Officer

Compensation

$607,495

Born 1971(Age 55)
male
MK

Ms. Karen Aranki

Chief Human Resources Officer

Compensation

$450,175

female
MK

Ms. Kimberley E. Honeysett J.D.

Chief Legal Officer, General Counsel & Corporate Secretary

Compensation

$493,904

Born 1970(Age 56)
female
MC

Mr. Christopher John Belfiore

Director of Investor Relations

male
MS

Mr. Sunny S. Sanyal

President, Chief Executive Officer & Director

Compensation

$999,495

Born 1964(Age 62)
male
MM

Mr. Mark S. Jonaitis

Senior Vice President & GM of X-Ray Sources

Compensation

$532,893

Born 1962(Age 64)
male
MA

Mr. Andrew J. Hartmann

Senior Vice President & GM of X-ray Detectors

Compensation

$484,174

Born 1963(Age 63)
male
MS

Mr. Shaohua Liang

Vice President & MD for China

male
vrex

Varex Imaging Corporation Insider Positioning

VREX · NASDAQ

During the last 12 months, insiders have sold $141K worth of VREX shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

4.5K

50.24K

Net Activity

-50K

-$50K

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

3.2K

39.17K

Net Activity

-39K

-$39K

9-12 Months

Bought

0

0.00

Sold

5.6K

51.48K

Net Activity

-51K

-$51K

Top Buyers

No buying activity

Top Sellers

1
KJK

Kunkel Jay K.

Director

10.1K shares3 transactions

$102K

2
AKL

Aranki Karen L

Officer: Chief Human Resources Officer

3.2K shares1 transactions

$39K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $141K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$50K

Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.

Insider Participation

High Selling

2 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.

SEC Filings

VREX - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

December 29, 2025
February 12, 2026
2026
DEF 14A

DEF 14A 2025

N/A

December 30, 2024
February 13, 2025
2025
DEF 14A

DEF 14A 2024

N/A

December 27, 2023
February 08, 2024
2024
DEF 14A

DEF 14A 2023

N/A

December 28, 2022
February 09, 2023
2023
DEF 14A

DEF 14A 2022

N/A

December 28, 2021
February 10, 2022
2022
DEF 14A

DEF 14A 2021

N/A

December 30, 2020
February 11, 2021
2021
DEF 14A

DEF 14A 2020

N/A

January 02, 2020
February 13, 2020
2020
DEF 14A

DEF 14A 2019

N/A

January 02, 2019
February 14, 2019
2019
DEF 14A

DEF 14A 2018

N/A

January 03, 2018
February 15, 2018
2018
Showing 1 to 9 of 9 filings